Physician profile
John D Martin
NPI 1538176482
$171,638.66
in general payments reported to CMS, 2019-2025
12 companies · $147K in 2025
The $147K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,327 · 2021: $362 · 2022: $610 · 2023: $975 · 2024: $3,884 · 2025: $147K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $133K · Travel and Lodging: $16K · Food and Beverage: $3,007 · Long Term Medical Supply Or Device Loan: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $133,050.00 |
| Travel and Lodging | $15,745.64 |
| Food and Beverage | $3,006.98 |
| Long Term Medical Supply Or Device Loan | $385.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Butterfly Network, INC. | $120,500.00 | 2025 | |
| Endologix LLC | $25,677.80 | 2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Collaborative Care Diagnostics, LLC | $13,975.02 | 2019-2023 | |
| Silk Road Medical, INC. | $5,601.08 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic Vascular, INC. | $3,379.28 | 2019 | |
| Intact Vascular, INC. | $933.12 | 2019 | |
| Boston Scientific Corporation | $609.40 | 2025 | Enroute Transcarotid Neuroprotection System |
| Eko Health, INC. | $385.00 | 2025 | |
| Medtronic, INC. | $298.44 | 2023-2025 | Endurant Iis |
| Philips North America LLC | $168.48 | 2023-2024 | (5028) Igt Devices Systems Undivided |
| Cook Medical LLC | $75.27 | 2024 | Zenith Spiral-Z |
| Edwards Lifesciences Corporation | $35.77 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.